Development of Acute Pancreatitis Due to Pegylated Interferon Alpha 2a in a Patient with Chronic Hepatitis B: A Case Report


Creative Commons License

Kose Ş., Turken M., Tanrisev M., Akkoclu G.

VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, vol.21, no.1, pp.35-37, 2015 (ESCI, TRDizin) identifier

Abstract

Interferons (IFNs) are immunomodulatory and antiviral agents used in the treatment of chronic hepatitis B and C. Development of acute pancreatitis is a very rare complication seen during IFN (pegylated or standard) treatment in chronic viral hepatitis. In this report, we present a 50-year-old patient with chronic renal insufficiency and chronic hepatitis B who developed acute pancreatitis during treatment with peg-IFN alpha-2a.